CN104817519B - 一类ca-4的衍生物、其制法及其医药用途 - Google Patents

一类ca-4的衍生物、其制法及其医药用途 Download PDF

Info

Publication number
CN104817519B
CN104817519B CN201510235806.3A CN201510235806A CN104817519B CN 104817519 B CN104817519 B CN 104817519B CN 201510235806 A CN201510235806 A CN 201510235806A CN 104817519 B CN104817519 B CN 104817519B
Authority
CN
China
Prior art keywords
acid
arh
compound
ethyl acetate
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510235806.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN104817519A (zh
Inventor
徐云根
刘坤
宋晓翰
陈泓竹
张宏波
张灵芝
朱启华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Pharmaceutical University
Original Assignee
China Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Pharmaceutical University filed Critical China Pharmaceutical University
Priority to CN201510235806.3A priority Critical patent/CN104817519B/zh
Publication of CN104817519A publication Critical patent/CN104817519A/zh
Application granted granted Critical
Publication of CN104817519B publication Critical patent/CN104817519B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
CN201510235806.3A 2015-05-11 2015-05-11 一类ca-4的衍生物、其制法及其医药用途 Active CN104817519B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510235806.3A CN104817519B (zh) 2015-05-11 2015-05-11 一类ca-4的衍生物、其制法及其医药用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510235806.3A CN104817519B (zh) 2015-05-11 2015-05-11 一类ca-4的衍生物、其制法及其医药用途

Publications (2)

Publication Number Publication Date
CN104817519A CN104817519A (zh) 2015-08-05
CN104817519B true CN104817519B (zh) 2016-11-16

Family

ID=53728020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510235806.3A Active CN104817519B (zh) 2015-05-11 2015-05-11 一类ca-4的衍生物、其制法及其医药用途

Country Status (1)

Country Link
CN (1) CN104817519B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109006694A (zh) * 2018-08-15 2018-12-18 广州星燎生物科技有限公司 一种肝癌鸡胚绒毛尿囊膜m-cdx模型的建立方法
CN108990900A (zh) * 2018-08-15 2018-12-14 广州星燎生物科技有限公司 一种肺癌鸡胚绒毛尿囊膜m-cdx模型及制备方法

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138427A2 (en) * 2005-06-14 2006-12-28 Baylor University Combretastatin analogs with tubulin binding activity
WO2009118474A1 (fr) * 2008-02-28 2009-10-01 Sanofi-Aventis Procede de preparation de combretastatine
EP2338877A1 (en) * 2009-12-15 2011-06-29 The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin Combretastatin Derivatives and Uses Therefor
CN102219811A (zh) * 2011-04-14 2011-10-19 中国药科大学 Ca-4衍生物、其制法及其医药用途
CN102249987A (zh) * 2011-05-06 2011-11-23 兰州大学 一种考布他汀类化合物及其制备方法和用途
CN102863472A (zh) * 2012-10-15 2013-01-09 中国海洋大学 考布他汀a-4类似物及其制备方法和在制备抗肿瘤药物中的应用
CN102906076A (zh) * 2009-12-03 2013-01-30 赛诺菲 考布他汀衍生物制备方法
WO2013026942A1 (en) * 2011-08-25 2013-02-28 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Tubulin binding agents
CN102985410A (zh) * 2010-05-05 2013-03-20 拜罗伊特大学 在癌症的治疗中使用的考布他汀类似物
CN103421057A (zh) * 2013-08-14 2013-12-04 合肥医工医药有限公司 康普瑞汀氨基糖缀合物、其制法及其医药用途
CN103524349A (zh) * 2013-10-19 2014-01-22 山东大学 Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途
WO2014181085A1 (en) * 2013-05-09 2014-11-13 Kenneth Dawson Bagshawe Tumour therapy

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138427A2 (en) * 2005-06-14 2006-12-28 Baylor University Combretastatin analogs with tubulin binding activity
WO2009118474A1 (fr) * 2008-02-28 2009-10-01 Sanofi-Aventis Procede de preparation de combretastatine
CN102906076A (zh) * 2009-12-03 2013-01-30 赛诺菲 考布他汀衍生物制备方法
EP2338877A1 (en) * 2009-12-15 2011-06-29 The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin Combretastatin Derivatives and Uses Therefor
CN102985410A (zh) * 2010-05-05 2013-03-20 拜罗伊特大学 在癌症的治疗中使用的考布他汀类似物
CN102219811A (zh) * 2011-04-14 2011-10-19 中国药科大学 Ca-4衍生物、其制法及其医药用途
CN102249987A (zh) * 2011-05-06 2011-11-23 兰州大学 一种考布他汀类化合物及其制备方法和用途
WO2013026942A1 (en) * 2011-08-25 2013-02-28 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Tubulin binding agents
CN102863472A (zh) * 2012-10-15 2013-01-09 中国海洋大学 考布他汀a-4类似物及其制备方法和在制备抗肿瘤药物中的应用
WO2014181085A1 (en) * 2013-05-09 2014-11-13 Kenneth Dawson Bagshawe Tumour therapy
CN103421057A (zh) * 2013-08-14 2013-12-04 合肥医工医药有限公司 康普瑞汀氨基糖缀合物、其制法及其医药用途
CN103524349A (zh) * 2013-10-19 2014-01-22 山东大学 Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
考布他汀A-4衍生物CPU-XT-006对人脐静脉内皮细胞增殖、凋亡及VEGF、bFGF表达的影响;何书英,等;《中国药科大学学报》;20131231;第44卷(第5期);第451-454页 *

Also Published As

Publication number Publication date
CN104817519A (zh) 2015-08-05

Similar Documents

Publication Publication Date Title
CN104583218B (zh) 作为蛋白酶活化受体4(par4)抑制剂用于治疗血小板聚集的咪唑并噻二唑和咪唑并吡嗪的衍生物
ES2320320T3 (es) Nuevos compuestos de isoxazol y tiazol y uso de los mismos como farmacos.
CN101715450B (zh) 作为cftr调控剂的氮杂吲哚衍生物
CN109152933A (zh) 诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途
AU2015226855A1 (en) Human plasma kallikrein inhibitors
ES2672992T3 (es) Compuesto aromático
CN109476635A (zh) 用于治疗疾病的二取代吡唑类化合物
MXPA02007035A (es) Compuesto ciclico conteniendo nitrogeno y composicion farmaceutica conteniendo el compuesto.
TW200404060A (en) Fused heterocyclic compounds
CN109384782A (zh) 取代五元并六元杂环类化合物、其制备方法、药物组合及其用途
ES2773994T3 (es) Inhibidores de grelina O-aciltransferasa
CN107151250A (zh) 嘧啶类七元环化合物、其制备方法、药用组合物及其应用
CA3090493A1 (en) Substituted benzothiophene analogs as selective estrogen receptor degraders
CN101143845A (zh) 取代喹啉甲酰胍衍生物、其制备方法及其医药用途
CN105722835A (zh) 3-芳基-5-取代的-异喹啉-1-酮化合物及它们的疗法应用
BR112020014584A2 (pt) inibição do canal iônico do receptor de potencial transitório a1
PT1320526E (pt) Derivados de sulfonamida activos a nível farmacêutico
CN106573907A (zh) 新颖的喹啉衍生物及其用于神经退化性疾病的用途
CN104817519B (zh) 一类ca-4的衍生物、其制法及其医药用途
CN108463222A (zh) 用于治疗疾病的杂环化合物
CN106573901A (zh) 富马酸酯类似物及其在治疗自身免疫性疾病或炎性疾病中的用途
CN106892920A (zh) 苦豆碱衍生物、其制备方法及用途
CN107207476A (zh) 吲哚和氮杂吲哚衍生物及其用于神经退化性疾病中的用途
CN105237444B (zh) 异羟肟酸类化合物及其制备方法和用途
CN106117182A (zh) 喹唑啉‑n‑苯乙基四氢异喹啉类化合物及其制备方法和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant